LBL-043, a novel LILRB4xCD3 T cell engager, for the treatment of LILRB4 positive leukemia

被引：0
|
作者：
Dang, Yujia
Huang, Xiao
Qin, Yurong
Liu, Xiaoya
Chen, Min
Jiang, Duqing
Wu, Guojin
Ye, Mi
Sun, Jianming
Wang, Baohui
Guan, Jing
Li, Tingting
Zhu, Jordan
Lai, Shoupeng
Kang, Xiaoqiang
Ling, Hong
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-6712
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6712
引用
收藏
页数：3
相关论文
共 34 条
  • [11] A Novel Anti-LILRB4 CAR-T Cell for the Treatment of Monocytic AML
    John, Samuel
    Chen, Heyu
    Deng, Mi
    Gui, Xun
    Wu, Guojin
    Chen, Weina
    Li, Zunling
    Zhang, Ningyan
    An, Zhiqiang
    Zhang, Cheng Cheng
    MOLECULAR THERAPY, 2018, 26 (10) : 2487 - 2495
  • [12] The inhibitory receptor LILRB4 (ILT3) modulates antigen presenting cell phenotype and, along with LILRB2 (ILT4), is upregulated in response to Salmonella infection
    Brown, Damien P.
    Jones, Des C.
    Anderson, Katie J.
    Lapaque, Nicolas
    Buerki, Robin A.
    Trowsdale, John
    Allen, Rachel L.
    BMC IMMUNOLOGY, 2009, 10 : 56
  • [13] LILRB4 ITIMs mediate the T cell suppression and infiltration of acute myeloid leukemia cells (vol 14, pg 256, 2019)
    Li, Zunling
    Deng, Mi
    Huang, Fangfang
    Jin, Changzhu
    Sun, Shuang
    Chen, Heyu
    Liu, Xiaoye
    He, Licai
    Sadek, Ali H.
    Zhang, Cheng Cheng
    CELLULAR & MOLECULAR IMMUNOLOGY, 2020, 17 (03) : 302 - 304
  • [14] The inhibitory receptor LILRB4 (ILT3) modulates antigen presenting cell phenotype and, along with LILRB2 (ILT4), is upregulated in response to Salmonella infection
    Damien P Brown
    Des C Jones
    Katie J Anderson
    Nicolas Lapaque
    Robin A Buerki
    John Trowsdale
    Rachel L Allen
    BMC Immunology, 10
  • [15] Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development
    Gui, Xun
    Deng, Mi
    Song, Hao
    Chen, Yuanzhi
    Xie, Jingjing
    Li, Zunling
    He, Licai
    Huang, Fangfang
    Xu, Yixiang
    Anami, Yasuaki
    Yu, Hai
    Yu, Chenyi
    Li, Leike
    Yuan, Zihao
    Xu, Xiaoying
    Wang, Qihui
    Chai, Yan
    Huang, Tao
    Shi, Yi
    Tsuchikama, Kyoji
    Liao, X. Charlene
    Xia, Ningshao
    Gao, George F.
    Zhang, Ningyan
    Zhang, Cheng Cheng
    An, Zhiqiang
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (08) : 1244 - 1257
  • [16] Antibodies to ILT3 (LILRB4) abrogate myeloid immunosuppression and combine with PD1 blockade to enable T cell activation and function
    Brandish, Philip
    Baker, Jeanne
    Byford, Alan
    Caniga, Michael
    Chappell, Craig
    Cherwinski, Holly
    Cua, Daniel
    Fayadat-dilman, Laurence
    Hall, Brian
    Joyce-Shaikh, Barbara
    Juan, Veronica
    Mieczkowski, Carl
    Palmieri, Anthony
    Qu, Yujie
    Singh, Latika
    Stiivers, Peter
    Zhang-Hoover, Jie
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [17] Microglia LILRB4 upregulation reduces brain damage after acute ischemic stroke by limiting CD8+ T cell recruitment
    Ma, Yilin
    Zheng, Kai
    Zhao, Chengcheng
    Chen, Jieli
    Chen, Lin
    Zhang, Yue
    Chen, Tao
    Yao, Xiuhua
    Cai, Ying
    Wu, Jialing
    JOURNAL OF NEUROINFLAMMATION, 2024, 21 (01)
  • [18] REGN4018, a novel MUC16xCD3 bispecific T-cell engager for the treatment of ovarian cancer
    Crawford, Alison
    Haber, Lauric
    Vazzana, Kristin
    Canova, Lauren
    Ram, Priyanka
    Principio, Jennifer
    Pawashe, Arpita
    Colleton, Curtis
    Kelly, Marcus
    Makkonen, Sosina
    Hickey, Carlos
    Duramad, Paurene
    Godin, Stephen
    Lin, John
    Smith, Eric
    Thurston, Gavin
    Kirshner, Jessica R.
    CANCER RESEARCH, 2018, 78 (13)
  • [19] Identification of Targetable Tumor Associated Proteins in Adult T-Acute Lymphoblastic Leukemia/Lymphoma (T-ALL/LBL) Including a Novel CC-Chemokine 4 (CCR4)-Positive T-ALL/LBL with Unique Immunophenotype
    Khurana, Sharad
    Heckman, Michael G.
    Cochuyt, Jordan
    Craig, Fiona E.
    Rahman, Zaid Abdel
    Greipp, Patricia
    Sproat, Lisa Z.
    Litzow, Mark
    Foran, James M.
    Jiang, Liuyan
    BLOOD, 2019, 134
  • [20] Targeting CD38 with isatuximab and a novel CD38/CD3xCD28 trispecific T-cell engager in older patients with acute myeloid leukemia
    Martin-Sanchez, Esperanza
    Blanco, Laura
    Kim, Peter S.
    Bisht, Kamlesh
    Wang, Hongfang
    van de Velde, Helgi
    Jelinek, Tomas
    Simoes, Catia
    Prosper, Felipe
    Miguel, Jesus F. San
    Alfonso, Ana
    Bergua, Juan
    Rodriguez-Veiga, Rebeca
    Vives, Susana
    Martinez-Cuadron, David
    Montesinos, Pau
    Paiva, Bruno
    Zabaleta, Aintzane
    BLOOD ADVANCES, 2024, 8 (15) : 3875 - 3879
1234